Clinical Trials Logo

Anal Fissure clinical trials

View clinical trials related to Anal Fissure.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT02667535 Withdrawn - Anal Fissure Clinical Trials

PK, PD and Safety Comparative Trial of Isosorbide Mononitrate Gel in Healthy Participants and With Anal Fissure

Start date: July 2017
Phase: Phase 1
Study type: Interventional

This is a Phase I trial to evaluate Pharmacokinetics, Pharmacodynamics and Safety of Isosorbide Mononitrate gel for usage in participants with anal fissure and healthy volunteers. Three doses will be used in patients with anal fissure (0.5%, 1.0% or 2.0%) and healthy volunteers will receive 2.0% dose. All treatment will last 7 days.

NCT ID: NCT01920074 Withdrawn - Anal Fissure Clinical Trials

Pharmacokinetic,Safety and Exploratory Efficacy of RECTIV® in Adolescents With Chronic Anal Fissure

Start date: June 2013
Phase: Phase 4
Study type: Interventional

RECTIV® is an ointment containing 0.4% nitroglycerin (NTG) for the treatment of moderate to severe pain associated with chronic anal fissure approved in June 2011 by the US Food and Drug Administration (FDA) for adults. The purpose of this study is to assess the safety, pharmacokinetics, and exploratory efficacy of RECTIV® in adolescents